Pavilion Health Today
Supporting healthcare professionals to deliver the best patient care

Spotlight: human papillomavirus virus conditions

The HPV vaccine has been part of the routine childhood vaccination schedule for 12-13-year-old girls for the past decade, and in July 2018, the JCVI announced that vaccination should be extended to boys too. This overview looks at the importance of vaccination and future possibilities.

  Introduction Human papillomavirus and benign conditionsHPV vaccination Future possibilitiesReferences Introduction HPV is the cause of almost all cervical cancers, and vaccination against high-risk HPV cancer-inducing strains (HR-HPV) have been part of the routine vaccination programme for 12 and 13-year-old girls in the UK for 10 years. HPV infection is now recognised as an aetiology in anogenital cancers and oropharyngeal cancers. HPV can also cause anogenital warts (condyloma acuminata) and other subtypes can cause verrucae and skin warts. HPV vaccination schedules have recently altered to include an older age group of susceptible individuals, i.e. men who have sex with men

---------------------------

This content is restricted to members of Pavilion Health Today. If you are an existing user, please log in. New users may register for free below.

Existing Users Log In
   
New User Registration
captcha
*Required field
author avatar
Dr Jane Wilcock

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more ...

Privacy & Cookies Policy